For more information please contact +1 (888) 605-6579

Cancer Therapy

Cell therapies are commonly used in Europe as an addition to traditional cancer treatment. Many patients look for alternative options to chemotherapy.  International statistics show that chemotherapy has only about a 2% success rate. While mainstream cancer therapies most definitely have their place in the treatment of cancer, no major advancements have been made in the last 25 years despite the release of many new drugs. For this reason, cell therapy   is an excellent additional therapy that may be able to improve outcomes of therapy.

Complementary cell therapy in the treatment of cancer has 2 functions:

  • Immune modulation using thymus
  • Organ fortification and rejuvenation with organ specific extracts


Examples of the use of Cell Therapy

Lung Cancer

Thymus extract was given twice a week for 10 weeks to 12 patients suffering from either undifferentiated cell carcinoma or squamous cell carcinoma.


  • Subjective and objective clinical improvements were seen in 10 of the 12 patients.
  • Local tumor growth was stopped and metastatic spread to mediastinal lymph nodes or other organs was decreased.
  • 3 patients experienced a partial regression of tumor mass.
  • The 6 month survival rate was increased to 42% in the treated group, compared to 7% in the control group    receiving only symptomatic treatment

Skotnicki published these results in 1989.


Hodgkin’s disease (lymphogranulomatosis)

Thymus extract was used in a program involving 366 children suffering from Hodgkin’s disease. These children also had other immune disorders.


  • There was an improvement in their immune system parameters.
  • 93.8% of the cases reached the 5-year survival rate compared to 70-80% of cases treated with radiation and chemotherapy

These results were published in 1991 -92 by Berkow and Makhonova


Breast Cancer

A group of 26 women with breast cancer was treated with thymus extract twice a week for 4-6 weeks. These women had previously undergone mastectomy 1 to 2 years before the study began.


  •  The CEA tumor marker dropped in approximately 70% of the cases treated with thymus extracts. This is compared to    47% in the group not undergoing cell therapy.

Another  study conducted over 15 years on 457 patients suffering breast cancer as well as cancer of the gastrointestinal tract showed that patients receiving cell therapy had:

  •  Less post-operative complications
  • Better and faster wound healing
  • Increased survival time compared to subjects receiving no cell therapy


Liver Cancer

A small pilot study on patients treated with thymus extract alone showed tumor regression in almost 50% of cases.